Crypto treasury companies and blockchain technology are creating alternative pathways to fund early-stage scientific and medical research. Biomedical and scientific companies are turning to blockchain technology and crypto treasury strategies to fund research, overhauling traditional capital formation and research funding structures that can delay life-saving cures by decades.Portage Biotech, a biomedical technology company, pivoted to become a Toncoin (TON) treasury company in September, earning operating revenues from staking to secure the network and investing in Telegram ecosystem projects, including games and mini-apps.The company will funnel some of the revenue generated from the operating business and the capital appreciation of TON to fund cancer research, AlphaTON CEO Brittany Kaiser told Cointelegraph. Read more Crypto treasury companies and blockchain technology are creating alternative pathways to fund early-stage scientific and medical research. Biomedical and scientific companies are turning to blockchain technology and crypto treasury strategies to fund research, overhauling traditional capital formation and research funding structures that can delay life-saving cures by decades.Portage Biotech, a biomedical technology company, pivoted to become a Toncoin (TON) treasury company in September, earning operating revenues from staking to secure the network and investing in Telegram ecosystem projects, including games and mini-apps.The company will funnel some of the revenue generated from the operating business and the capital appreciation of TON to fund cancer research, AlphaTON CEO Brittany Kaiser told Cointelegraph. Read more

Crypto treasuries and blockchain are paving the way for decentralized science

2025/11/16 02:04

Crypto treasury companies and blockchain technology are creating alternative pathways to fund early-stage scientific and medical research.

Biomedical and scientific companies are turning to blockchain technology and crypto treasury strategies to fund research, overhauling traditional capital formation and research funding structures that can delay life-saving cures by decades.

Portage Biotech, a biomedical technology company, pivoted to become a Toncoin (TON) treasury company in September, earning operating revenues from staking to secure the network and investing in Telegram ecosystem projects, including games and mini-apps.

The company will funnel some of the revenue generated from the operating business and the capital appreciation of TON to fund cancer research, AlphaTON CEO Brittany Kaiser told Cointelegraph. 

Read more

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like